Kazakhstan Implements Ban on E-Cigarettes and Vaping Products

Regulations by 2FIRSTS.ai
Jun.20.2024
Kazakhstan Implements Ban on E-Cigarettes and Vaping Products
Kazakhstan officially bans sales, distribution, and import of e-cigarette products, with severe penalties for violations, effective today.

According to Tengrinews.kz, on June 20th, Kazakhstan officially implemented a new regulation today that aims to prohibit the sale, distribution, and import of e-cigarette products.

 

According to the recently passed Health Issues Amendment Act, popular e-cigarettes or disposable e-cigarettes are now banned in Kazakhstan. Although using e-cigarettes will not be penalized, selling, promoting, and importing these products will be subject to criminal liability.

 

According to the revised clauses in the Health Law, adjustments have also been made in the Criminal Law. Now, a new Article 301-1 has been added to the law, governing the circulation of non-tobacco products, electronic consumption systems (e-cigarettes), spices, and their e-liquids. Part 1 sets forth penalties for the sale and dissemination of e-cigarettes: fines of up to 200 MRP (738,400 junko or $1602.67 USD in 2024), or up to 200 hours of community service, or up to 50 days of detention. Part 2 stipulates penalties for the import and production of e-cigarettes: fines of up to 2000 MRP (730,000 junko or $15,844 USD in 2024), or up to 600 hours of community service, or up to 2 years of restriction or deprivation of liberty.

 

If these actions are repeatedly carried out by criminal groups and involve particularly large amounts of income, the penalties will be more severe: fines up to 5000 MRP (equivalent to 1.84 million Jankos in 2024 [39,936 US dollars]), or up to 1200 hours of community service, or a maximum of 5 years of restriction/deprivation of freedom.

 

In response to an official inquiry from Tengrinews.kz, the Ministry of Internal Affairs of Kazakhstan stated:

 

The act of distributing e-cigarettes should be understood as passing on e-cigarettes to others. This behavior will lead to criminal liability, regardless of its form, and regardless of whether there is any material or other benefits.

 

Smoking e-cigarettes in inappropriate places will result in the same penalties as smoking traditional cigarettes— a fine of 3 MRP (11,076 kongos [24.04 USD]) in 2024.

 

In addition, the amendment introduced a precise definition of e-cigarettes in the "People's Health and Hygiene System Code.

 

Electronic consumer systems (e-cigarettes) flavorings; electronic consumer systems (e-cigarettes) and their liquids; non-smoking tobacco products; products imitating tobacco products. Previously, on April 19th, President of Kazakhstan Kassym-Jomart Tokayev signed the "Law amending and supplementing certain laws and regulations regarding health issues in the Republic of Kazakhstan".

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

France’s HAS to Address Role of E-Cigarettes in Updated Smoking-Cessation Guidelines, Tells 2Firsts
France’s HAS to Address Role of E-Cigarettes in Updated Smoking-Cessation Guidelines, Tells 2Firsts
2Firsts has learned that France’s national health authority, the Haute Autorité de Santé (HAS), confirmed the role of e-cigarettes will be addressed in updated national smoking-cessation guidelines expected by the end of 2026. HAS said the recommendations will focus on clinical and public-health considerations, will not set technical standards for vaping products, and that current studies are insufficient to clearly assess risks and benefits across different product categories.
Mar.10
Indiana SB 185 Advances: Foreign-Made Vapes Would Be Barred, With Focus on China
Indiana SB 185 Advances: Foreign-Made Vapes Would Be Barred, With Focus on China
Indiana State Sen. Ron Alting is backing Senate Bill 185, which would ban vape shops in Indiana from selling any foreign-made vaping products and restrict retail shelves to U.S.-made items. Alting has framed the proposal as a consumer-safety measure and has singled out China, citing industry reporting that China produces more than 90% of the world’s vape hardware.
Jan.27 by 2FIRSTS.ai
France drops a vaping clause from the 2026 finance bill after use of Article 49.3
France drops a vaping clause from the 2026 finance bill after use of Article 49.3
A provision in France’s 2026 finance bill intended to regulate vaping products was abandoned after Sébastien Lecornu used Article 49.3 on January 20 to commit the government’s responsibility on the “revenue” section of the state budget.
Jan.21 by 2FIRSTS.ai
Product | Claiming a “first multi-beverage vaporizer” with refillable juice/cocktail water chamber, PEAKBAR launches new device in the U.S.
Product | Claiming a “first multi-beverage vaporizer” with refillable juice/cocktail water chamber, PEAKBAR launches new device in the U.S.
PEAKBAR’s new H2O 40K has begun selling through U.S. online retailers including Vape Sourcing. Marketed as the “world’s first multi-beverage vaporizer,” the device is promoted as allowing users to add liquids such as juice and cocktails into a water chamber for pairing. Publicly listed specifications include 20 ml of e-liquid, a rated 40,000 puffs, 0.5% nicotine, a 1,000 mAh rechargeable battery, and two power modes at 22W and 12W.
Jan.22 by 2FIRSTS.ai
China Caps E-Cigarette Capacity and Requires Export Compliance Proof to Curb “Involution”
China Caps E-Cigarette Capacity and Requires Export Compliance Proof to Curb “Involution”
China’s top tobacco regulator has issued a directive aimed at preventing excess capacity and curbing “involution-style” competition in the e-cigarette sector. The notice tightens investment controls, formalizes verified capacity management and requires exporters to submit compliance proof for destination markets, signaling a push toward higher industry concentration and stricter cross-border oversight.
Special Report
Feb.13
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24